List of Chapters/Sections(Table Of Content)
1 Neurovascular Devices Market Overview
1.1 Product Overview and Scope of Neurovascular Devices
1.2 Neurovascular Devices Segment by Type
1.2.1 Global Neurovascular Devices Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 Aneurysm Coiling & Embolization Devices
1.2.3 Cerebral Balloon Angioplasty & Stenting Systems
1.2.4 Support Devices
1.2.5 Neurothrombectomy Devices
1.3 Neurovascular Devices Segment by Application
1.3.1 Global Neurovascular Devices Sales Comparison by Application: (2021-2027)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Units
1.4 Global Neurovascular Devices Market Size Estimates and Forecasts
1.4.1 Global Neurovascular Devices Revenue 2016-2027
1.4.2 Global Neurovascular Devices Sales 2016-2027
1.4.3 Neurovascular Devices Market Size by Region: 2016 Versus 2021 Versus 2027
2 Neurovascular Devices Market Competition by Manufacturers
2.1 Global Neurovascular Devices Sales Market Share by Manufacturers (2016-2021)
2.2 Global Neurovascular Devices Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Neurovascular Devices Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Neurovascular Devices Manufacturing Sites, Area Served, Product Type
2.5 Neurovascular Devices Market Competitive Situation and Trends
2.5.1 Neurovascular Devices Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Neurovascular Devices Players Market Share by Revenue
2.5.3 Global Neurovascular Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Neurovascular Devices Retrospective Market Scenario by Region
3.1 Global Neurovascular Devices Retrospective Market Scenario in Sales by Region: 2016-2021
3.2 Global Neurovascular Devices Retrospective Market Scenario in Revenue by Region: 2016-2021
3.3 North America Neurovascular Devices Market Facts & Figures by Country
3.3.1 North America Neurovascular Devices Sales by Country
3.3.2 North America Neurovascular Devices Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Neurovascular Devices Market Facts & Figures by Country
3.4.1 Europe Neurovascular Devices Sales by Country
3.4.2 Europe Neurovascular Devices Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Neurovascular Devices Market Facts & Figures by Region
3.5.1 Asia Pacific Neurovascular Devices Sales by Region
3.5.2 Asia Pacific Neurovascular Devices Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Neurovascular Devices Market Facts & Figures by Country
3.6.1 Latin America Neurovascular Devices Sales by Country
3.6.2 Latin America Neurovascular Devices Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Neurovascular Devices Market Facts & Figures by Country
3.7.1 Middle East and Africa Neurovascular Devices Sales by Country
3.7.2 Middle East and Africa Neurovascular Devices Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Neurovascular Devices Historic Market Analysis by Type
4.1 Global Neurovascular Devices Sales Market Share by Type (2016-2021)
4.2 Global Neurovascular Devices Revenue Market Share by Type (2016-2021)
4.3 Global Neurovascular Devices Price by Type (2016-2021)
5 Global Neurovascular Devices Historic Market Analysis by Application
5.1 Global Neurovascular Devices Sales Market Share by Application (2016-2021)
5.2 Global Neurovascular Devices Revenue Market Share by Application (2016-2021)
5.3 Global Neurovascular Devices Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Stryker Corporation
6.1.1 Stryker Corporation Corporation Information
6.1.2 Stryker Corporation Description and Business Overview
6.1.3 Stryker Corporation Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Stryker Corporation Neurovascular Devices Product Portfolio
6.1.5 Stryker Corporation Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Corporation Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Johnson & Johnson Neurovascular Devices Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 Medtronic
6.3.1 Medtronic Corporation Information
6.3.2 Medtronic Description and Business Overview
6.3.3 Medtronic Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Medtronic Neurovascular Devices Product Portfolio
6.3.5 Medtronic Recent Developments/Updates
6.4 Terumo
6.4.1 Terumo Corporation Information
6.4.2 Terumo Description and Business Overview
6.4.3 Terumo Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Terumo Neurovascular Devices Product Portfolio
6.4.5 Terumo Recent Developments/Updates
6.5 Penumbra
6.5.1 Penumbra Corporation Information
6.5.2 Penumbra Description and Business Overview
6.5.3 Penumbra Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Penumbra Neurovascular Devices Product Portfolio
6.5.5 Penumbra Recent Developments/Updates
6.6 Microport Scientific Corporation
6.6.1 Microport Scientific Corporation Corporation Information
6.6.2 Microport Scientific Corporation Description and Business Overview
6.6.3 Microport Scientific Corporation Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Microport Scientific Corporation Neurovascular Devices Product Portfolio
6.6.5 Microport Scientific Corporation Recent Developments/Updates
6.7 Abbott Vascular
6.6.1 Abbott Vascular Corporation Information
6.6.2 Abbott Vascular Description and Business Overview
6.6.3 Abbott Vascular Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Abbott Vascular Neurovascular Devices Product Portfolio
6.7.5 Abbott Vascular Recent Developments/Updates
6.8 W. L. Gore & Associates
6.8.1 W. L. Gore & Associates Corporation Information
6.8.2 W. L. Gore & Associates Description and Business Overview
6.8.3 W. L. Gore & Associates Neurovascular Devices Sales, Revenue and Gross Margin (2016-2021)
6.8.4 W. L. Gore & Associates Neurovascular Devices Product Portfolio
6.8.5 W. L. Gore & Associates Recent Developments/Updates
7 Neurovascular Devices Manufacturing Cost Analysis
7.1 Neurovascular Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Neurovascular Devices
7.4 Neurovascular Devices Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Neurovascular Devices Distributors List
8.3 Neurovascular Devices Customers
9 Neurovascular Devices Market Dynamics
9.1 Neurovascular Devices Industry Trends
9.2 Neurovascular Devices Growth Drivers
9.3 Neurovascular Devices Market Challenges
9.4 Neurovascular Devices Market Restraints
10 Global Market Forecast
10.1 Neurovascular Devices Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Neurovascular Devices by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Neurovascular Devices by Type (2022-2027)
10.2 Neurovascular Devices Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Neurovascular Devices by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Neurovascular Devices by Application (2022-2027)
10.3 Neurovascular Devices Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Neurovascular Devices by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Neurovascular Devices by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
